What is the recommended endoscopic surveillance interval for patients at high risk for pancreatic cancer?
- There is currently no consensus for the optimum endoscopic surveillance interval in individuals determined to be at increased risk for pancreatic neoplasia.
- Some medical centers advocate surveillance EUS in high-risk patients every 2 to 3 years, with the interval decreasing to every 12 months as the patient approaches the age when pancreatic cancer developed in the youngest affected relative.
